An Introduction to Machine Learning.


Journal

Clinical pharmacology and therapeutics
ISSN: 1532-6535
Titre abrégé: Clin Pharmacol Ther
Pays: United States
ID NLM: 0372741

Informations de publication

Date de publication:
04 2020
Historique:
received: 08 10 2019
accepted: 15 01 2020
pubmed: 5 3 2020
medline: 28 10 2020
entrez: 5 3 2020
Statut: ppublish

Résumé

In the last few years, machine learning (ML) and artificial intelligence have seen a new wave of publicity fueled by the huge and ever-increasing amount of data and computational power as well as the discovery of improved learning algorithms. However, the idea of a computer learning some abstract concept from data and applying them to yet unseen situations is not new and has been around at least since the 1950s. Many of these basic principles are very familiar to the pharmacometrics and clinical pharmacology community. In this paper, we want to introduce the foundational ideas of ML to this community such that readers obtain the essential tools they need to understand publications on the topic. Although we will not go into the very details and theoretical background, we aim to point readers to relevant literature and put applications of ML in molecular biology as well as the fields of pharmacometrics and clinical pharmacology into perspective.

Identifiants

pubmed: 32128792
doi: 10.1002/cpt.1796
pmc: PMC7189875
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

871-885

Informations de copyright

© 2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.

Références

N Engl J Med. 2019 Apr 4;380(14):1347-1358
pubmed: 30943338
Clin Pharmacol Ther. 2016 Oct;100(4):371-9
pubmed: 26950176
Support Care Cancer. 2006 Aug;14(8):831-6
pubmed: 16482450
J Chem Inf Model. 2013 Feb 25;53(2):461-74
pubmed: 23293925
Br J Clin Pharmacol. 2006 Oct;62(4):420-34
pubmed: 16995863
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28242672
Drug Discov Today. 2005 Apr 1;10(7):471-83
pubmed: 15809193
Neural Netw. 2005 Jun-Jul;18(5-6):826-34
pubmed: 16109475
Am Rev Respir Dis. 1989 Dec;140(6):1573-7
pubmed: 2690704
Bioinformatics. 2015 May 1;31(9):1396-404
pubmed: 25573913
Artif Intell Med. 2010 Oct;50(2):105-15
pubmed: 20638252
Lancet Digit Health. 2019 May;1(1):e17-e25
pubmed: 33323237
Clin Pharmacol Ther. 2010 Jul;88(1):52-9
pubmed: 20220749
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Stat Med. 2010 Feb 10;29(3):337-46
pubmed: 19960510
CPT Pharmacometrics Syst Pharmacol. 2019 Mar;8(3):131-134
pubmed: 30549240
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):207-220
pubmed: 30718832
J Mol Graph Model. 2012 Apr;34:108-17
pubmed: 22326864
Arch Toxicol Suppl. 1985;8:173-88
pubmed: 3868347
Cell. 2018 Jun 14;173(7):1581-1592
pubmed: 29887378
Methods. 2014 Jun 1;67(3):304-12
pubmed: 24657666
PLoS Comput Biol. 2019 Jun 20;15(6):e1006907
pubmed: 31220072
Pharmacogenomics J. 2014 Jun;14(3):208-16
pubmed: 24217556
BMC Cancer. 2006 Jun 30;6:174
pubmed: 16813650
Pediatr Res. 2019 Jul;86(1):122-127
pubmed: 30928997
Clin Pharmacokinet. 2015 Apr;54(4):409-21
pubmed: 25403847
Oper Res. 1980 Jan-Feb;28(1):97-113
pubmed: 10297741
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Annu Rev Biomed Eng. 2017 Jun 21;19:221-248
pubmed: 28301734
J Pharmacokinet Pharmacodyn. 2002 Jun;29(3):271-307
pubmed: 12449499
Methods. 2017 Oct 1;129:81-88
pubmed: 28549952
Neural Comput. 1997 Nov 15;9(8):1735-80
pubmed: 9377276
Springerplus. 2016 Aug 09;5(1):1304
pubmed: 27547678
PLoS Comput Biol. 2008 Oct;4(10):e1000173
pubmed: 18974822
J Autoimmun. 2009 Nov-Dec;33(3-4):197-207
pubmed: 19819109
J Am Med Inform Assoc. 2017 Mar 1;24(2):361-370
pubmed: 27521897
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4304-E4311
pubmed: 29666228

Auteurs

Solveig Badillo (S)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Balazs Banfai (B)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Fabian Birzele (F)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Iakov I Davydov (II)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Lucy Hutchinson (L)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Tony Kam-Thong (T)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Juliane Siebourg-Polster (J)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Bernhard Steiert (B)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Jitao David Zhang (JD)

Pharmaceutical Sciences, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH